Evidence map›Paper›PMID 37854718›Full record

ArticleFrontiers in pharmacology2023

Quercetagetin alleviates zearalenone-induced liver injury in rabbits through Keap1/Nrf2/ARE signaling pathway.

Fengyang Wu, Fengxia Wang, Zhaohong Tang, Xinyu Yang, Yanhua Liu, Man Zhao, Shudong Liu, Shuaijuan Han, Zhisheng Zhang, Baojiang Chen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Toxins · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Dietary quercetagetin attenuates HFrontiers in veterinary science · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Fengyang Wu *College of Animal Science and Technology, Hebei Agricultural University, Baoding, China.
Fengxia Wang *College of Animal Science and Technology, Hebei Agricultural University, Baoding, China.
Zhaohong Tang *Hebei Research Institute of Microbiology Co., Ltd., Baoding, China.
Xinyu YangCollege of Animal Science and Technology, Hebei Agricultural University, Baoding, China.
Yanhua LiuCollege of Animal Science and Technology, Hebei Agricultural University, Baoding, China.
Man ZhaoCollege of Animal Science and Technology, Hebei Agricultural University, Baoding, China.
Shudong LiuCollege of Animal Science and Technology, Hebei Agricultural University, Baoding, China.
Shuaijuan HanCollege of Animal Science and Technology, Hebei Agricultural University, Baoding, China.
Zhisheng ZhangCollege of Animal Science and Technology, Hebei Agricultural University, Baoding, China.
Baojiang ChenCollege of Animal Science and Technology, Hebei Agricultural University, Baoding, China.
Hebei Agricultural University · CNHebei Research Institute of Microbiology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Keap1/Nrf2/ARE signaling pathwayliver injuryQuercetagetinrabbitZearalenone

Identifiers

PMID37854718
PMCPMC10579610
OpenAlexW4387308917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.